RAPS is now seeking applications for the 2016 class of RAPS Fellows. Being named a RAPS Fellow is a unique and exceptional achievement within the regulatory profession. Since 2008, the RAPS Fellows program has recognized senior-level regulatory professionals for continued significant contributions to, and leadership in advancing, the global regulatory profession.
“Selection as a RAPS Fellow is an honor and an important recognition of those individuals who have contributed to the growing relevance of our profession,” said Fellows Selection Committee Chair Sue Stewart, president of Stewart Regulatory Consulting LLC. “By attracting these RAPS members to the Fellows we seek to harness this expertise in ways meant to benefit the broader regulatory community.”
The 2016 Fellows will be honored during RAPS’ Regulatory Convergence conference to take place 17–20 September in San Jose, CA, USA.
Fellows come from a variety of backgrounds and represent many different aspects within the diverse worldwide regulatory community, including those who work in industry, government, academia, research and clinical organizations, and other settings. Regardless of background, they share a persistent dedication to regulatory excellence. See the full list of all RAPS Fellows.
In addition to being honored during the Regulatory Convergence, Fellows will be entitled to hold the FRAPS designation. They may also be called upon to participate in strategic dialogue, implementation of special initiatives, international programs and other high-level RAPS activities.
2016 Fellows applications will be due to RAPS approximately 26 May. To apply, visit the RAPS Fellows Application and Selection Process page.
The 2015 RAPS Fellows (pictured above L to R) were: Karen Bannick McQuoid, FRAPS, principal and founder, Bannick Consulting LLC; Patricia Anderson, FRAPS, RAC, vice president, regulatory service, MAPI; Marcela Saad, FRAPS, RAC, president and senior consultant, MaroM Consulting; Sabina Hoekstra-van den Bosch, FRAPS, senior manager regulations and standards, Philips; Gert Bos, FRAPS, PhD, head of regulatory and clinical affairs, BSI Notified Body; Heather Rosecrans, FRAPS, executive vice president, medical devices and combination products, GreenLeaf Health LLC; Arthur Brandwood, FRAPS, PhD, chief executive officer, Brandwood Biomedical; Claudia Ising, FRAPS, head of regulatory affairs, Lohmann & Rauscher GmbH & Co. KG; Margaret Mucha, FRAPS, director of global regulatory affairs, Mortara Instruments Inc.; and Jennifer Paine, FRAPS, RAC, executive vice president, worldwide quality, regulatory and compliance, Ortho Clinical Diagnostics Inc.